Combined modality treatment of resectable and borderline resectable pancreas cancer: Expert consensus statement Journal Article
| Authors: | Abrams, R. A.; Lowy, A. M.; O'Reilly, E. M.; Wolff, R. A.; Picozzi, V. J.; Pisters, P. W. T. |
| Article Title: | Combined modality treatment of resectable and borderline resectable pancreas cancer: Expert consensus statement |
| Keywords: | cancer chemotherapy; cancer survival; cancer surgery; overall survival; clinical trial; cancer localization; cisplatin; erlotinib; fluorouracil; cancer combination chemotherapy; multimodality cancer therapy; treatment duration; antineoplastic agents; clinical trials as topic; conference paper; alpha interferon; capecitabine; gemcitabine; paclitaxel; adjuvant therapy; cancer adjuvant therapy; cancer patient; cancer radiotherapy; comparative study; disease free survival; pancreas cancer; pancreas resection; postoperative care; preoperative care; radiation dose; chemotherapy, adjuvant; combined modality therapy; neoadjuvant therapy; pancreatic neoplasms; radiotherapy, adjuvant; research design |
| Journal Title: | Annals of Surgical Oncology |
| Volume: | 16 |
| Issue: | 7 |
| ISSN: | 1068-9265 |
| Publisher: | Springer |
| Date Published: | 2009-07-01 |
| Start Page: | 1751 |
| End Page: | 1756 |
| Language: | English |
| DOI: | 10.1245/s10434-009-0413-9 |
| PUBMED: | 19390900 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 14" - "Export Date: 30 November 2010" - "CODEN: ASONF" - "Source: Scopus" |
